Parabolic Drugs Ltd.
BSE: 533211 | Sector: Health care |
NSE: PARABDRUGS | ISIN Code: INE618H01016 |
BSE 00:00 | 25 Jan | Parabolic Drugs Ltd Not listed in BSE |
NSE 05:30 | 01 Jan | Parabolic Drugs Ltd Not listed in NSE |
OPEN | 5.70 |
PREVIOUS CLOSE | 5.70 |
VOLUME | 21 |
52-Week high | 5.70 |
52-Week low | 0.00 |
P/E | |
Mkt Cap.(Rs cr) | 35 |
Buy Price | 6.35 |
Buy Qty | 1649.00 |
Sell Price | 5.70 |
Sell Qty | 56019.00 |
About Parabolic Drugs Ltd.
Parabolic Drugs Ltd is one of the fast growing API (Active Pharmaceutical Ingredients) and API intermediate manufacturing and marketing company. The company is in SME segment with increasing international presence and a strong R&D foundation. The company is based in Chandigarh. They have one subsidiary company namely Parabolic Research Labs Ltd.The company produces the SSP and Cephalosporin range ...> More
Parabolic Drugs Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
35 | |
EPS - TTM | (![]() |
[*S] | - |
P/E Ratio | (X) | [*S] | - |
Face Value | (![]() |
10 | |
Latest Dividend | (%) | 2.50 | |
Latest Dividend Date | 24 Sep 2012 | ||
Dividend Yield | (%) | 0.00 | |
Book Value / Share | (![]() |
[*S] | -154.10 |
P/B Ratio | (![]() |
[*S] | -0.04 |
Announcement
-
Outcome Of Board Meeting Held On 11.02.2021 And Intimation Of Financial Results For The Quarter And
-
Corporate Insolvency Resolution Process (CIRP)-Public Announcement
-
Parabolic Drugs Limited - Corporate Insolvency Resolution Process
-
Board Meeting Intimation for Un-Audited Quarterly Financial Results For The Quarter And Nine Months
Parabolic Drugs Ltd - Financial Results
Particulars (![]() |
Dec 2020 | Dec 2019 | % Chg |
Net Sales | - | ||
Other Income | 0.23 | - | |
Total Income | 0.23 | - | |
Total Expenses | 0.84 | 1.71 | -50.88 |
Operating Profit | -0.61 | -1.71 | 64.33 |
Net Profit | -6.05 | -7.22 | 16.2 |
Equity Capital | 61.89 | 61.89 | - |
Parabolic Drugs Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Vivo Bio Tech | 32.20 | -0.62 | 47.91 |
Godavari Drugs | 61.30 | -0.41 | 46.16 |
Decipher Labs | 42.95 | -1.04 | 43.38 |
Oxygenta Pharma | 24.50 | 2.08 | 34.79 |
Zenith Health | 6.01 | -1.15 | 32.27 |
Vista Pharma. | 7.00 | 0.14 | 25.76 |
Concord Drugs | 28.70 | 13.66 | 25.08 |
Parabolic Drugs Ltd - SHAREHOLDING PATTERN
|
|
Parabolic Drugs Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | NA | NA | 1.23% | 1.35% |
1 Month | NA | NA | -3.11% | -3.07% |
3 Month | NA | NA | -7.67% | -7.97% |
6 Month | NA | NA | -8.15% | -8.03% |
1 Year | NA | NA | 0.84% | 0.22% |
3 Year | 586.75% | NA | 34.99% | 34.45% |
Parabolic Drugs Ltd - STOCK STRENGTH
Today's Low/High | 5.70 | 5.70 | |
Week Low/High | 0.00 | 5.70 | |
Month Low/High | 0.00 | 5.70 | |
YEAR Low/High | 0.00 | 5.70 | |
All TIME Low/High | 0.59 | 79.00 |
Quick Links for Parabolic Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices